Upper Respiratory Infection
📧 Sign up to get email alerts when something new happens for Upper Respiratory Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Point of Care Respiratory Pathogen Testing for Antibiotic Stewardship in Primary Care [NA]
Clinical trial update about a study evaluating point-of-care respiratory pathogen testing to support antibiotic stewardship in primary care.…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV
The TRUST-RSV trial in Türkiye is studying RSV-positive children under 5 presenting to pediatric emergency departments, and the study is cur…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat [NA]
The document notes that a clinical trial evaluating a mouth and throat rinse for acute sore throat has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Evaluating the Potential of Large Language Models for Respiratory Disease Consultations [NA]
This completed clinical trial evaluated the potential of large language models to assist respiratory disease consultations. It covered multi…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI) [NA]
Completed clinical trial evaluating a novel Sinusonic device for prevention of community-acquired upper respiratory infection with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) [Phase 4]
Phase 4 trial evaluating the efficacy and safety of MUCOLASE Tablet (Streptokinase • Streptodornase) for acute upper respiratory infection a…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
Phase IV clinical trial assessing the efficacy and safety of Fuganlin Oral Liquid in children with acute upper respiratory infection; the st…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) [Phase 4]
Phase 4 trial completion evaluating the efficacy and safety of Fuganlin Oral Liquid in children with acute upper respiratory infection.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada
This clinical trial update examines the impact of introducing the pneumococcal vaccine PHiD-CV (Synflorix) for Nunavik children. It covers o…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Treatment of Influenza in Routine Clinical Practice
This document reports the completion of a clinical trial that examined treatments for influenza in routine clinical practice.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
The study on gas supply, demand, and middle ear gas balance (Specific Aim 2) under the sponsor Cuneyt M. Alper has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection [Phase 3]
A Phase 3 clinical trial evaluating pelubiprofen and loxoprofen for acute upper respiratory infection has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection [Phase 4]
Phase 4 post-marketing study update evaluating Jinyebaidu Granule for acute upper respiratory infection.
-
CLINICAL_TRIALS withdrawal · 2015-05-15Clinical Trial Update: Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs) [NA]
This clinical trial comparing supportive therapies for symptom relief in pediatric acute upper respiratory infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds [Phase 4]
Phase 4 trial updating on montelukast to prevent nasal symptoms during colds; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI [Phase 3]
Phase 3 trial evaluating warming sensation intensity, flavor acceptability, and local tolerability of paracetamol 500 mg + pseudoephedrine 3…
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Appropriate Care of URI (ACURI): Early Head Start [NA]
The ACURI trial evaluating appropriate care of upper respiratory infection in Early Head Start programs has completed. No clinical results a…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection [NA]
A terminated clinical trial compared a novel pasteurized maple cough syrup formulation to placebo for nocturnal cough and sleep quality in i…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Improving Communication During Pediatric Visits for Acute Respiratory Illness [NA]
This update reports the completion of a University of Washington clinical trial focused on improving communication during pediatric visits f…
-
CLINICAL_TRIALS trial_result · 2007-06-18Clinical Trial Update: Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection. [Phase 2]
A completed Phase 2 pilot clinical trial evaluating CVT-E002 for pediatric upper respiratory tract infections.